Section Arrow
CTOR.NASDAQ
- Citius Oncology Inc
Quotes are at least 15-min delayed:2025/07/04 16:12 EDT
Last
 5.29
+0.07 (+1.34%)
Day High 
5.8899 
Prev. Close
5.22 
1-M High
6.19 
Volume 
647.47K 
Bid
5.22
Ask
5.32
Day Low
4.9 
Open
4.905 
1-M Low
0.89 
Market Cap 
373.50M 
Currency USD 
P/E 150 
%Yield -- 
10-SMA 3.49 
20-SMA 2.38 
50-SMA 1.46 
52-W High 49 
52-W Low 0.5506 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.38/0.05
Enterprise Value
377.30M
Balance Sheet
Book Value Per Share
0.50
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed:2025/07/04 16:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.